JM Gamble

Dr. JM Gamble is a Clinical Associate Professor and Associate Director of Graduate Studies and Research at the University of Waterloo's School of Pharmacy. His research focuses on drug safety and effectiveness, particularly in diabetes therapies, and explores methods to communicate drug information for evidence-informed decisions. He leads the Gamble Lab, which investigates real-world drug use and health outcomes.

Education: PhD in Public Health Science (University of Alberta, 2012), MSc in Clinical Epidemiology (2008), BSc in Pharmacy (2005), and BSc in Biology (Lakehead University, 2001).

Research Interests:

• Post-marketing drug safety
• Comparative effectiveness
• Pharmacoepidemiology
• Diabetes health outcomes
• Drug information science

Recent work emphasizes systematic reviews on drug harms, hypoglycemia risks, and the impact of SGLT2 inhibitors. His studies often use population-based data and epidemiological methods.

Awards:

• 2017 Primary Healthcare Researcher of the Year
• CIHR New Investigator Award (2013–2018)
• Canadian Diabetes Association Clinician Scientist Award (2013–2018)

Teaching: Courses include PHARM 220/222 (Patient-Centered Care), PHARM 377 (Drug-Induced Disease), and PHARM 656 (Quantitative Health Data Analysis).

Labs/Teams: Director of the Gamble Lab, collaborating on drug safety and evidence translation projects.